AZ044

CAS No. 1800017-49-5

AZ044( —— )

Catalog No. M34168 CAS No. 1800017-49-5

AZ044 is a potent, selective inhibitor of type III phosphatidylinositol-4-kinase alpha-subtype (PI4KIIIalpha).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 135 In Stock
5MG 117 In Stock
10MG 188 In Stock
25MG 432 In Stock
50MG 732 In Stock
100MG 1190 In Stock
200MG 1609 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AZ044
  • Note
    Research use only, not for human use.
  • Brief Description
    AZ044 is a potent, selective inhibitor of type III phosphatidylinositol-4-kinase alpha-subtype (PI4KIIIalpha).
  • Description
    PI4K-IN-1 (compound 44) is a potent PI4KIII inhibitor, with pIC50 values of 9.0 and 6.6 for PI4KIIIα and PI4KIIIβ, respectively. PI4K-IN-1 also inhibits PI3Kα/β/γ/δ, with pIC50 values of 4.0/<3.7/5.0/<4.1, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI4K
  • Recptor
    PI4K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1800017-49-5
  • Formula Weight
    437.55
  • Molecular Formula
    C24H27N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (285.68 mM; Ultrasonic )
  • SMILES
    N(C[C@@H]1CC[C@@H](C(O)=O)CC1)C=2SC=3C(N2)=CC=C(C3)C4=CC(=O)N(CC5CC5)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Raubo P, et al. Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα). Bioorg Med Chem Lett. 2015 Aug 15;25(16):3189-93. ?
molnova catalog
related products
  • KDU-691

    KDU-691 is a potent, selective, orally active parasite PI4K inhibitor.

  • PI4KA inhibitor A1

    PI4KA inhibitor A1 (GSK-A1) is a highly specific and potent inhibitor of PI4KA.

  • GSK-F1

    GSK-F1 is a novel potent PI4KA inhibitor.